Pharmaceutical giant GSK’s chief commercial officer, Luke Miels, will become CEO in January 2026, succeeding Dame Emma Walmsley after nearly a decade in charge. Walmsley, who became the first woman to lead a major global pharmaceutical company upon her appointment in 2017, has delivered what the business has described as a ‘comprehensive step-change’ in performance, … Continue reading Where are the female CEOs? GSK’s Walmsley latest to leave FTSE 100